|
시장보고서
상품코드
1565601
세계의 AI 지원 방사선 의학 시장 : 기술별, 용도별, 최종사용자별, 지역별 예측(-2032년)Global AI-assisted Radiology Market Research Report Information by Technique, by Application, by End User, and by Region - Forecast till 2032 |
||||||
세계 AI 지원 방사선 의학 시장 규모는 2023년 15억 7,000만 달러, 2024년 20억 3,000만 달러에서 예측 기간 동안 32.96%의 CAGR을 기록하며 2032년 271억 8,000만 달러 규모로 성장할 것으로 예상됩니다.
AI 지원 방사선 의학 시장은 AI를 활용한 의료 영상 진단 스타트업의 증가와 신규 진입자들의 전략적 노력에 힘입어 성장세를 보이고 있습니다. 자원과 비용의 제약으로 인해 시장 성장이 제한될 수 있지만, 전 세계적으로 의료 영상 처리를 위한 AI에 대한 자금 투입과 투자가 증가함에 따라 시장 성장에 유리한 기회를 제공할 것으로 예상됩니다.
지역별 전망
북미 시장은 다양한 요인으로 인해 상당한 성장세를 보이고 있습니다. 방사선 의학은 AI와 머신러닝의 발전으로 크게 발전하여 환자 결과 개선, 업무 간소화, 진단 정확도 향상에 기여하고 있습니다.
유럽의 AI 지원 방사선 의학 시장은 시장 점유율 2위를 차지하고 있으며, 이는 헬스케어 인프라가 잘 구축되어 있고 헬스케어 산업이 확대되고 있기 때문으로 분석됩니다.
아시아태평양 시장은 2024년부터 2032년까지 가장 빠른 성장세를 보일 것으로 예상됩니다. 이는 의료비 지출 증가, 온라인 소매 채널 확대, 정부 이니셔티브 및 투자에 기인합니다. 또한 AI 기술에 대한 투자도 증가하고 있습니다.
세계 AI 지원 방사선 의학 시장을 조사했으며, 시장의 정의와 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 시장 규모 추정 및 예측, 각종 부문별·지역별 분석, 경쟁 환경, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
제3장 조사 방법
제4장 시장 역학
- 성장 촉진요인
- AI를 활용한 의료 영상 스타트업 기업 증가
- 진출 기업에 의한 전략적 대처 확대
- 성장 억제요인
- 고비용과 자원상 제약
- 기회
- 세계적인 의료 영상 진단용 AI에 대한 자금·투자 증가
제5장 시장 요인 분석
- Porter's Five Forces 분석
- COVID-19가 세계의 방사선 AI 시장에 미치는 영향
제6장 세계의 AI 지원 방사선 의학 시장 : 기술별
- 개요
- X선
- 자기공명영상
- 컴퓨터 단층촬영(CT)
- 양전자 방출 단층촬영(PET)
- 기타
제7장 세계의 AI 지원 방사선 의학 시장 : 용도별
- 개요
- 신경
- 맘모그래피(유방암)
- 심혈관
- 호흡기·폐
- 정형외과
- 기타
제8장 세계의 AI 지원 방사선 의학 시장 : 최종사용자별
- 개요
- 병원
- 진단 영상 센터
- 기타
제9장 세계의 AI 지원 방사선 의학 시장 : 지역별
- 개요
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제10장 경쟁 상황
- 시장 점유율 분석
- 경쟁 대시보드
- 공개 기업 주식 개요
- 비교 분석 : 주요 기업 재무 동향
- 주요 전개·성장 전략
제11장 기업 개요
- KONINKLIJKE PHILIPS N.V.
- SIEMENS HEALTHINEERS AG
- CLARIPI INC
- CONTEXTVISION AB
- LUNIT INC.
- FUJIFILM HOLDINGS CORPORATION
- AGFA-GEVAERT GROUP
- GE HEALTHCARE
- ENLITIC, INC.
- NANO-X IMAGING LTD.
Global AI-assisted Radiology Market Research Report Information by Technique (X-rays, Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography (PET), and Others), by Application (Neurology, Mammography (Breast Cancer), Cardiovascular, Respiratory and Pulmonary, Orthopedics, and Others), by End User (Hospitals, Diagnostic Imaging Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World - Forecast till 2032
Market Overview
In 2023, the AI-assisted Radiology Market was estimated to be worth USD 1.57 billion. The AI-assisted Radiology Market industry is anticipated to experience a compound annual growth rate (CAGR) of 32.96% from USD 2.03 billion in 2024 to USD 27.18 billion by 2032 during the forecast period (2024-2032).
The AI-assisted Radiology Market is being driven by the increasing number of AI-powered medical imaging start-ups and the strategic initiatives of market players. Nevertheless, the global market's expansion is anticipated to be impeded by resource and cost constraints. However, it is anticipated that the market will generate lucrative opportunities as a result of the growing funding and investment in AI in medical imaging worldwide.
Market segment insights
The AI-assisted Radiology Market segmentation is defined by the technique used, which includes X-rays, magnetic resonance imaging, computed tomography, positron emission tomography (PET), and others.
The AI-assisted Radiology Market segmentation is categorized by application and includes neurology, mammography (breast cancer), cardiovascular, respiratory and pulmonary, orthopedics, and others.
Hospitals, diagnostic imaging centers, and other entities comprise the AI-assisted Radiology Market segmentation, which is based on end user.
Regional Perspectives
The market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World by region. Factors are propelling the substantial expansion of the North American AI-assisted Radiology market. Radiology has been revolutionized by advancements in artificial intelligence (AI) and machine learning, which have resulted in improved patient outcomes, streamlined operations, and increased diagnostic accuracy. This technical advancement addresses challenges such as the growing demand for effective healthcare delivery in the context of a radiology deficit and the increasing prevalence of chronic diseases.
The European AI-assisted Radiology market accounted for the second-largest market share, which is attributed to the well-established healthcare infrastructure and the expanding healthcare industry. Additionally, the Germany AI-assisted Radiology provider is considered to have the greatest market share, while the France AI-assisted Radiology providers are expected to have the fastest growing market in the European region.
The Asia-Pacific AI-assisted Radiology market is anticipated to experience the most rapid growth from 2024 to 2032. This is attributed to the increasing expenditure on healthcare, the expansion of online retail channels for healthcare products, and government initiatives and investments. Additionally, there is a rise in investments in AI technology.
Major Players
Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), ContextVision AB (Sweden), GE Healthcare (US), FUJIFILM Corporation (Japan), Agfa-Gevaert Group (Belgium), ClariPi Inc (South Korea), Lunit Inc (South Korea), Enlitic Inc. (US), and NANO-X IMAGING LTD (Israel) are among the key companies in the AI-assisted Radiology market.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
- 2.1 DEFINITION
- 2.2 SCOPE OF THE STUDY
- 2.3 RESEARCH OBJECTIVE
- 2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
- 3.1 OVERVIEW
- 3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
- 3.3 PURCHASED DATABASE:
- 3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
- 3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
- 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
- 3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TECHNIQUE
- 3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
- 3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
- 4.1 INTRODUCTION
- 4.2 DRIVERS
- 4.2.1 RISING NUMBER OF AI-POWERED MEDICAL IMAGING START- UPS
- 4.2.2 GROWING STRATEGIC INITIATIVES BY MARKET PLAYERS
- 4.3 RESTRAINTS
- 4.3.1 HIGH COST AND RESOURCE CONSTRAINTS
- 4.4 OPPORTUNITY
- 4.4.1 INCREASING FUNDING & INVESTMENT FOR AI IN MEDICAL IMAGING ACROSS THE GLOBE
5 MARKET FACTOR ANALYSIS
- 5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF RIVALRY
- 5.2 IMPACT OF COVID-19 ON THE GLOBAL AI IN RADIOLOGY MARKET
6 GLOBAL AI-ASSISTED RADIOLOGY MARKET, BY TECHNIQUE
- 6.1 OVERVIEW
- 6.2 X-RAYS
- 6.3 MAGNETIC RESONANCE IMAGING
- 6.4 COMPUTED TOMOGRAPHY (CT)
- 6.5 POSITRON EMISSION TOMOGRAPHY (PET)
- 6.6 OTHERS
7 GLOBAL AI-ASSISTED RADIOLOGY MARKET, BY APPLICATION
- 7.1 OVERVIEW
- 7.2 NEUROLOGY
- 7.3 MAMMOGRAPHY (BREAST CANCER)
- 7.4 CARDIOVASCULAR
- 7.5 RESPIRATORY AND PULMONARY
- 7.6 ORTHOPEDICS
- 7.7 OTHERS
8 GLOBAL AI-ASSISTED RADIOLOGY MARKET, BY END USER
- 8.1 OVERVIEW
- 8.2 HOSPITALS
- 8.3 DIAGNOSTIC IMAGING CENTERS
- 8.4 OTHERS
9 GLOBAL AI-ASSISTED RADIOLOGY, BY REGION
- 9.1 OVERVIEW
- 9.2 NORTH AMERICA
- 9.2.1 US
- 9.2.2 CANADA
- 9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 FRANCE
- 9.3.3 UK
- 9.3.4 ITALY
- 9.3.5 SPAIN
- 9.3.6 REST OF EUROPE
- 9.4 ASIA-PACIFIC
- 9.4.1 CHINA
- 9.4.2 INDIA
- 9.4.3 JAPAN
- 9.4.4 AUSTRALIA
- 9.4.5 SOUTH KOREA
- 9.4.6 REST OF ASIA-PACIFIC
- 9.5 REST OF THE WORLD
- 9.5.1 MIDDLE EAST & AFRICA
- 9.5.2 SOUTH AMERICA
10 COMPETITIVE LANDSCAPE
- 10.1 INTRODUCTION
- 10.2 MARKET SHARE ANALYSIS,
- 10.3 COMPETITOR DASHBOARD
- 10.4 PUBLIC PLAYERS STOCK SUMMARY
- 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
- 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.6.1 PRODUCT LAUNCH/SERVICE LAUNCH
- 10.6.2 COLLABORATION
- 10.6.3 EXPANSION
- 10.6.4 AGREEMENT
- 10.6.5 PARTNERSHIP
11 COMPANY PROFILES
- 11.1 KONINKLIJKE PHILIPS N.V.
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
- 11.2 SIEMENS HEALTHINEERS AG
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 SWOT ANALYSIS
- 11.2.6 KEY STRATEGIES
- 11.3 CLARIPI INC
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 KEY STRATEGIES
- 11.4 CONTEXTVISION AB
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 KEY STRATEGIES
- 11.5 LUNIT INC.
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 KEY STRATEGIES
- 11.6 FUJIFILM HOLDINGS CORPORATION
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 SWOT ANALYSIS
- 11.6.6 KEY STRATEGIES
- 11.7 AGFA-GEVAERT GROUP
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 SOLUTIONS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGIES
- 11.8 GE HEALTHCARE
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 SWOT ANALYSIS
- 11.8.6 KEY STRATEGIES
- 11.9 ENLITIC, INC.
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCTS OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 KEY STRATEGIES
- 11.10 NANO-X IMAGING LTD.
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 PRODUCT/SOLUTIONS OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 KEY STRATEGIES
